Breast Cancer PET/CT Imaging With 68Ga-pAKTi

Launched by FUDAN UNIVERSITY · Apr 17, 2025

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Voluntarily signs the informed consent form.
• • 2. Age ≥ 18 years.
• • 3. Pathologically confirmed or highly suspected breast cancer based on conventional imaging.
• • 4. Estimated life expectancy \> 3 months as determined by the physician.
• • 5. Agrees to practice strict contraception for at least 28 days following the PET/CT examination.
• • 6. Willing and able to comply with the study protocol.
• • 7. Has not undergone surgical resection of the lesion.
• • 8. Has participated in molecular testing at the Precision Oncology Center of Fudan University Shanghai Cancer Center, and harbors a PIK3CA mutation, PTEN mutation, or upregulation of the PI3K-AKT-mTOR pathway.
• Exclusion Criteria:
• • 1. Pregnant or breastfeeding women.
• • 2. Unable to lie still on the PET/CT scanner bed during the examination or intolerant to PET imaging.
• • 3. Participation in another interventional clinical trial within 1 month prior to screening.
• • 4. Patients who are lost to follow-up.
• • 5. Any other condition that, in the opinion of the investigator, may interfere with the study or make the subject unsuitable for participation.